Combination of Empagliflozin and Liraglutide protects heart against isoproterenol-induced myocardial infarction in rats
Cardiovascular benefit of new anti-hyperglycemic agent such as glucagon like peptide-1 receptor agonist (GLP-1RA) or sodium glucose co-transporter-2 inhibitor (SGLT2i) has been proven, with the proposed-mechanism that might be complementary. We investigated the effects of its combination on blood gl...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Book |
| Published: |
Pensoft Publishers,
2023-02-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|